September 2018

 

In this Supplement

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

Issue

European
Supplement

Download a PDF of this supplement

The Importance of Vessel Preparation

Properly preparing lesions before use of drug-eluting technologies has become a crucial step of the treatment algorithm.

By Ralf Langhoff, MD

How Can DCB Design Impact Clinical Outcomes?

The technology and clinical outcomes of the Passeo-18 Lux DCB.

By Marianne Brodmann, MD; and Gunnar Tepe, MD

How Self-Expanding Bare-Metal Stent Design Can Affect Procedural Results

Clinical outcomes in treatment of femoropopliteal artery disease with the Pulsar-18 stent.

By Jos C. van den Berg, MD, PhD; and Michael Lichtenberg, MD, FESC

Combining a Drug-Coated Balloon and a Bare-Metal Stent: The REsponse Adapted Combination Therapy (REACT) Strategy

Allowing vessel response to guide appropriate treatment for SFA disease.

By Koen Deloose, MD, and B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS

Assessing the Economic Impact of Peripheral Interventions

The difficulties in weighing cost-effectiveness in treatment algorithms remain.

By Yann Gouëffic, MD, PhD; and Valéry-Pierre Riche
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.